GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Product name : Boc_Ala
Catalog number : 2051
Supplier name : Sceti K.K.
Data sheet: Ask more or other datasheet now !
More Details about
Human sera, especially from patients with autoimmune diseases, contain high levels of immunoreactive components, which yield high background levels in ELISA systems. These non-specific reactions are caused by adhesive immunoglobulins contained in human serum, which strongly adhere to plastic surfaces by hydrophobic binding. Futhermore, blocking agents such as bovine serum albumin (BSA) and Tween 20, are not capable of blocking these non-specifi c reactions. However, these false positive reactions caused by serum sample itself have been misunderstood, and are considered as a real antibody-antigen reaction in many cases. In order to obtain the correct value of antigen-antibody reaction, it is critical 1) to choose proper blocking agents which effectively block these kinds of non-specifi c reactions, 2) to determine a unique non-specifi c background value of individual samples using antigen-non-coated wells and 3) to subtract the background value from the value determined in antigen-coated wells.
In addition, it is necessary to determine the non-specifi c reactions caused by the secondary antibody as well. Chondrex’s ELISA system incorporates unique blocking agents that inhibit the hydrophobic binding of these serum components onto plastic surfaces and are designed to determine the background values of individual samples using antigen-non-coated wells.
In general, antibodies to collagen in human sera are highly specifi c to heterologous collagen such as bovine or chick type I and/or type II collagen and cross-react to other species and types of collagen including human collagen, regardless of the disease. For example, serum antibodies even from healthy normal controls react to various species and types of collagen. To determine the human serum antibodies with a signifi cant diversity in the antigen specifi city, Chondrex provides various species of type I and type II collagen-coated strips as well as uncoated wells (see table above). This ELISA kit contains enough materials to run two plates on two separate occasions (see assay procedure) and may be used for monkey sera as well as human sera.
NOTES BEFORE USING ASSAY
Note 1: It is recommended that the standard and samples be run in duplicate.
Note 2: Partially used reagents may be kept at –20°C.
Note 3: Crystals may form in the 20X wash buffer when stored at cold temperatures. If crystals have formed, it is necessary to warm the wash buffer by placing the bottle in warm water until crystals have dissolved completely.
Note 4: Measure exact volume of buffers using a serological pipette prior to diluting. Extra buffer is provided.
1. Dilute Wash Buffer: Dilute 50 ml of 20X wash buffer in 950 ml of distilled water (1X wash buffer). Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
2. Add Blocking Buffer: Add 100 µl of Blocking Buffer (Solution A) to all wells. Incubate for 1 hour at room temperature.
3. Prepare Standard Dilutions: Undiluted standard is 16 units/ml. Prepare serial dilutions of the standard by mixing 250 µl of 16 units/ml standard with 250 µl of Sample/Standard Dilution Buffer (Solution B) - 8 units/ml . Then repeat this procedure to make five more serial dilutions of standard - 4, 2, 1, 0.5 and 0.25 units/ml solutions. The 16 units/ml standard may be stored at -20°C for use in a second assay. We recommend making fresh serial dilutions for each assay.
4. Prepare Sample Dilutions: Dilute samples 1:100 or more with Solution B. For example, dilute 20 µl of sample with 1.98 ml of Solution B (1:100). Keep this as a stock solution for future assays. If necessary, dilute the samples further with Solution B, 1:200-1:1000.
Note: Human serum samples have a high lipid content in general. In order to avoid non-specifi c reactions caused by lipids, centrifuge samples at 10,000 rpm for 5 minutes using a tabletop centrifuge. Take a desired volume of serum sample carefully by pipette and then wipe the pipette surface with paper.
5. Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
6. Add Standards and Samples: Add 100 µl of standards, Solution B (blank), and samples to collagen coated and uncoated wells in duplicate. Incubate at 4°C overnight.
7. Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
8. Add Secondary Antibody: Dissolve one vial of secondary antibody in 10 ml Secondary Antibody Dilution Buffer (Solution C).
Add 100 µl of secondary antibody solution to each well and incubate at room temperature for 2 hours.
9. Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
10. OPD: Dissolve one vial of OPD in 10 ml of OPD Dilution Buffer just prior to use. Add 100 µl of OPD solution to each well immediately after washing the plate. Incubate for 30 minutes at room temperature.
11. Stop: Add 50 µl of 2N sulfuric acid (Stop Solution) to each well.
12. Read Plate: Read the OD values at 490 nm. If the OD values of samples are greater than the OD values of the highest standard, re-assay the samples at a higher dilution. A 630 nm fi lter can be used as a reference.
CALCULATION OF ANTIBODY TITERS
1. Average the duplicate OD values for the standards, blanks (B) and test samples in uncoated wells and collagen coated wells.
2. Subtract the blank (B) values from the averaged OD values of the standards and test samples in uncoated wells and collagen coated wells.
Note: Individual antigens have unique background values. Therefore, “blank” wells should be used for each different antigen.
3. Subtract the OD values of samples tested in uncoated wells (background values) from their counterpart OD values in collagen coated wells from step 2 to eliminate values associated with non-specifi c reactions.
4. Plot the OD values of standards against the units/mL of antibody standard. Using a log/log plot will linearize the data. Figure 3 shows a representative experiment where the standard range is from 0.25 to 16 units/ml.
5. The units/mL of antibody in test samples can be calculated using regression analysis.
Note: 100 units is approximately 1 µg IgG antibody/ml.
Contact us about this product :
Our team will respond you as soon as possible !
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
No related Items
Related Genes :
[Boc] Brother of CDO (Protein BOC)
[BOC UNQ604/PRO1190] Brother of CDO (Protein BOC)
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[SHH] Sonic hedgehog protein (SHH) (HHG-1) [Cleaved into: Sonic hedgehog protein N-product; Sonic hedgehog protein C-product]
[ATP7B PWD WC1 WND] Copper-transporting ATPase 2 (EC 188.8.131.52) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa]
[Shh Hhg1] Sonic hedgehog protein (SHH) (HHG-1) [Cleaved into: Sonic hedgehog protein N-product (Sonic hedgehog protein 19 kDa product); Sonic hedgehog protein C-product (Sonic hedgehog protein 27 kDa product)]
[F8 F8C] Coagulation factor VIII (Antihemophilic factor) (AHF) (Procoagulant component) [Cleaved into: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain]
[AR DHTR NR3C4] Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)
[CTNNB1 CTNNB OK/SW-cl.35 PRO2286] Catenin beta-1 (Beta-catenin)
[FBN1 FBN] Fibrillin-1 [Cleaved into: Asprosin]
[SCN5A] Sodium channel protein type 5 subunit alpha (HH1) (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5)
[HBB] Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin]
[TTN] Titin (EC 184.108.40.206) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)
[cox1] Cytochrome c oxidase subunit 1 (EC 220.127.116.11) (Fragment)
[SCN1A NAC1 SCN1] Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1)
[COL1A1] Collagen alpha-1(I) chain (Alpha-1 type I collagen)
[BRCA1 RNF53] Breast cancer type 1 susceptibility protein (EC 18.104.22.168) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1)
[SOD1] Superoxide dismutase [Cu-Zn] (EC 22.214.171.124) (Superoxide dismutase 1) (hSod1)
[EGFR ERBB ERBB1 HER1] Epidermal growth factor receptor (EC 126.96.36.199) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
[KCNH2 ERG ERG1 HERG] Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)
[KCNQ1 KCNA8 KCNA9 KVLQT1] Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1)
[OASA1 OAS1 OASS OLD3 At4g14880 dl3480c] Cysteine synthase 1 (EC 188.8.131.52) (At.OAS.5-8) (Beta-substituted Ala synthase 1;1) (ARAth-Bsas1;1) (CSase A) (AtCS-A) (Cys-3A) (O-acetylserine (thiol)-lyase 1) (OAS-TL A) (O-acetylserine sulfhydrylase) (Protein ONSET OF LEAF DEATH 3)
[COI] Cytochrome c oxidase subunit 1 (EC 184.108.40.206) (Fragment)
[IGF2 PP1446] Insulin-like growth factor II (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin]
[COX3] Cytochrome c oxidase subunit 3 (Fragment)
[ALA3 ITB2 At1g59820 F23H11.14] Phospholipid-transporting ATPase 3 (AtALA3) (EC 220.127.116.11) (Aminophospholipid ATPase 3) (Aminophospholipid flippase 3) (Protein IRREGULAR TRICHOME BRANCH 2)
[PRSS1 TRP1 TRY1 TRYP1] Trypsin-1 (EC 18.104.22.168) (Beta-trypsin) (Cationic trypsinogen) (Serine protease 1) (Trypsin I) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2]
[IHH] Indian hedgehog protein (IHH) (HHG-2) [Cleaved into: Indian hedgehog protein N-product; Indian hedgehog protein C-product]
[MLH1 COCA2] DNA mismatch repair protein Mlh1 (MutL protein homolog 1)
[CXCL8 IL8] Interleukin-8 (IL-8) (C-X-C motif chemokine 8) (Chemokine (C-X-C motif) ligand 8) (Emoctakin) (Granulocyte chemotactic protein 1) (GCP-1) (Monocyte-derived neutrophil chemotactic factor) (MDNCF) (Monocyte-derived neutrophil-activating peptide) (MONAP) (Neutrophil-activating protein 1) (NAP-1) (Protein 3-10C) (T-cell chemotactic factor) [Cleaved into: MDNCF-a (GCP/IL-8 protein IV) (IL8/NAP1 form I); Interleukin-8 ((Ala-IL-8)77) (GCP/IL-8 protein II) (IL-8(1-77)) (IL8/NAP1 form II) (MDNCF-b); IL-8(5-77); IL-8(6-77) ((Ser-IL-8)72) (GCP/IL-8 protein I) (IL8/NAP1 form III) (Lymphocyte-derived neutrophil-activating factor) (LYNAP) (MDNCF-c) (Neutrophil-activating factor) (NAF); IL-8(7-77) (GCP/IL-8 protein V) (IL8/NAP1 form IV); IL-8(8-77) (GCP/IL-8 protein VI) (IL8/NAP1 form V); IL-8(9-77) (GCP/IL-8 protein III) (IL8/NAP1 form VI)]
 Neutrophil serine proteases exert proteolytic activity on endothelial cells.
 A colorimetric assay that specifically measures Granzyme B proteolytic activity: hydrolysis of Boc-Ala-Ala-Asp-S-Bzl.
 Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity.
 Radical acylation of L-lysine derivatives and L-lysine-containing peptides by peroxynitrite-treated diacetyl and methylglyoxal.
 An efficient method for the synthesis of phenacyl ester-protected dipeptides using neutral alumina-supported sodium carbonate 'Na2 CO3 /n-Al2 O3 '.
 Correlations between steric/thermochemical parameters and O-/N-acylation reactions of cellulose.
 Molecular analysis of the membrane insertion domain of proteinase 3, the Wegener's autoantigen, in RBL cells: implication for its pathogenic activity.
 Selective and reversible thiol-pegylation, an effective approach for purification and characterization of five fully active ficin (iso)forms from Ficus carica latex.
 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
 A time-resolved spectroscopic comparison of the photoisomerization of small beta-turn-forming thioxopeptides.
Enter catalog number :